Competing with precision: incentives for developing predictive biomarker tests

dc.contributor.authorBrekke, Kurt R.por
dc.contributor.authorDalen, Dag Mortenpor
dc.contributor.authorStraume, Odd Runepor
dc.date.accessioned2022-03-25T10:50:56Z
dc.date.available2022-03-25T10:50:56Z
dc.date.issued2022-03
dc.description.abstractWe study the incentives of drug producers to develop predictive biomarkers, taking into account strategic interaction between drug producers and health plans.For this purpose we develop a two-dimensional spatial frame work that allows us to capture the informational role of biomarkers and their effects on price competition and treatment choices. Although biomarkers increase the information available to prescribers, we identify an anticompetitive effect on the prices set by producers of therapeutically substitutable drugs. We also find that better information about each patient's most therapeutically appropriate drug does not necessarily lead to more efficient treatment outcomes.por
dc.distributioninternationalpor
dc.identifier.urihttps://hdl.handle.net/1822/76660
dc.language.isoengpor
dc.peerreviewednopor
dc.publisherUniversidade do Minho. Núcleo de Investigação em Políticas Económicas (NIPE)por
dc.relation.publisherversionhttps://nipe.eeg.uminho.pt/publicacoes-nipe/#documentos-de-trabalhopor
dc.rightsopenAccesspor
dc.subjectPharmaceutical marketspor
dc.subjectPrecision medicinepor
dc.subjectTherapeutic competitionpor
dc.subjectPredictive biomarkerspor
dc.titleCompeting with precision: incentives for developing predictive biomarker testspor
dc.typeworkingPaperpor
dspace.entity.typePublicationen
oaire.citationConferencePlaceBraga, Portugalpor
oaire.citationEndPage47por
oaire.citationIssueNIPE WP 03/2022por
oaire.citationStartPage1por

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
WP_03_2022.pdf
Tamanho:
394.83 KB
Formato:
Adobe Portable Document Format
Descrição:
Competing with precision: incentives for developing predictive biomarker tests